scispace - formally typeset
Search or ask a question
Institution

Kanazawa Medical University

EducationKanazawa, Japan
About: Kanazawa Medical University is a education organization based out in Kanazawa, Japan. It is known for research contribution in the topics: Population & Cancer. The organization has 3103 authors who have published 6322 publications receiving 144592 citations. The organization is also known as: Kanazawa ika daigaku.


Papers
More filters
Journal ArticleDOI
TL;DR: The activation of SIRT1 in the kidney may be a new therapeutic target to increase resistance to many causal factors in the development of renal diseases, including diabetic nephropathy.
Abstract: Sirtuins are members of the Sir2 (silent information regulator 2) family, a group of class III deacetylases. Mammals have seven different sirtuins, SIRT1–SIRT7. Among them, SIRT1, SIRT3 and SIRT6 are induced by calorie restriction conditions and are considered anti-aging molecules. SIRT1 has been the most extensively studied. SIRT1 deacetylates target proteins using the coenzyme NAD+ and is therefore linked to cellular energy metabolism and the redox state through multiple signalling and survival pathways. SIRT1 deficiency under various stress conditions, such as metabolic or oxidative stress or hypoxia, is implicated in the pathophysiologies of age-related diseases including diabetes, cardiovascular diseases, neurodegenerative disorders and renal diseases. In the kidneys, SIRT1 may inhibit renal cell apoptosis, inflammation and fibrosis, and may regulate lipid metabolism, autophagy, blood pressure and sodium balance. Therefore the activation of SIRT1 in the kidney may be a new therapeutic target to increase resistance to many causal factors in the development of renal diseases, including diabetic nephropathy. In addition, SIRT3 and SIRT6 are implicated in age-related disorders or longevity. In the present review, we discuss the protective functions of sirtuins and the association of sirtuins with the pathophysiology of renal diseases, including diabetic nephropathy.

191 citations

Journal ArticleDOI
TL;DR: Restoring the renoprotective action of autophagy in proximal tubules may improve renal outcomes in obese patients and enhance the understanding of obesity-related cell vulnerability in the kidneys.
Abstract: Obesity is an independent risk factor for renal dysfunction in patients with CKDs, including diabetic nephropathy, but the mechanism underlying this connection remains unclear. Autophagy is an intracellular degradation system that maintains intracellular homeostasis by removing damaged proteins and organelles, and autophagy insufficiency is associated with the pathogenesis of obesity-related diseases. We therefore examined the role of autophagy in obesity-mediated exacerbation of proteinuria-induced proximal tubular epithelial cell damage in mice and in human renal biopsy specimens. In nonobese mice, overt proteinuria, induced by intraperitoneal free fatty acid–albumin overload, led to mild tubular damage and apoptosis, and activated autophagy in proximal tubules reabsorbing urinary albumin. In contrast, diet-induced obesity suppressed proteinuria-induced autophagy and exacerbated proteinuria-induced tubular cell damage. Proximal tubule-specific autophagy-deficient mice, resulting from an Atg5 gene deletion, subjected to intraperitoneal free fatty acid–albumin overload developed severe proteinuria-induced tubular damage, suggesting that proteinuria-induced autophagy is renoprotective. Mammalian target of rapamycin (mTOR), a potent suppressor of autophagy, was activated in proximal tubules of obese mice, and treatment with an mTOR inhibitor ameliorated obesity-mediated autophagy insufficiency. Furthermore, both mTOR hyperactivation and autophagy suppression were observed in tubular cells of specimens obtained from obese patients with proteinuria. Thus, in addition to enhancing the understanding of obesity-related cell vulnerability in the kidneys, these results suggest that restoring the renoprotective action of autophagy in proximal tubules may improve renal outcomes in obese patients.

191 citations

Journal ArticleDOI
TL;DR: It was found that HCV-PT, the prototype reported from the U.S.A., was rare in Japan, suggesting that distribution of HCV genotypes may be different in various countries, and the prevalence of HCVs genotypes was compared in different countries.

188 citations

Journal ArticleDOI
Emanuele Di Angelantonio1, Pei Gao1, Hassan Khan1, Adam S. Butterworth1, David Wormser1, Stephen Kaptoge1, Sreenivasa Rao Kondapally Seshasai2, Alexander M. W. Cargill Thompson1, Nadeem Sarwar1, Peter Willeit1, Paul M. Ridker3, Elizabeth L M Barr4, Kay-Tee Khaw1, Bruce M. Psaty5, Hermann Brenner6, Beverley Balkau7, Jacqueline M. Dekker8, Debbie A Lawlor9, Makoto Daimon10, Johann Willeit11, Inger Njølstad, Aulikki Nissinen, Eric J. Brunner12, Lewis H. Kuller13, Jackie F. Price14, Johan Sundström15, Matthew Knuiman16, Edith J. M. Feskens16, W.M.M. Verschuren, Nicholas J. Wald17, Stephan J. L. Bakker18, Peter H. Whincup2, Ian Ford19, Uri Goldbourt20, Agustin Gomez-de-la-Camara20, John Gallacher21, Leon A. Simons22, Annika Rosengren23, Susan E. Sutherland24, Cecilia Björkelund23, Dan G. Blazer25, Sylvia Wassertheil-Smoller26, Altan Onat27, Alejandro Marín Ibañez, Edoardo Casiglia28, J. Wouter Jukema29, Lara M. Simpson30, Simona Giampaoli31, Børge G. Nordestgaard32, Randi Selmer33, Patrik Wennberg34, Jussi Kauhanen35, Jukka T. Salonen36, Rachel Dankner37, Elizabeth Barrett-Connor38, Maryam Kavousi39, Vilmundur Gudnason40, Denis A. Evans41, Robert B. Wallace42, Mary Cushman43, Ralph B. D'Agostino44, Jason G. Umans45, Yutaka Kiyohara46, Hidaeki Nakagawa47, Shinichi Sato, Richard F. Gillum48, Aaron R. Folsom48, Yvonne T. van der Schouw49, Karel G.M. Moons49, Simon J. Griffin1, Naveed Sattar19, Nicholas J. Wareham1, Elizabeth Selvin50, Simon G. Thompson1, John Danesh1 
26 Mar 2014-JAMA
TL;DR: The improvement provided by HbA1c assessment in prediction of CVD risk was equal to or better than estimated improvements for measurement of fasting, random, or postload plasma glucose levels.
Abstract: IMPORTANCE The value of measuring levels of glycated hemoglobin (HbA(1c)) for the prediction of first cardiovascular events is uncertain. OBJECTIVE To determine whether adding information on HbA(1c ...

185 citations

Journal ArticleDOI
15 Oct 2016
TL;DR: The activation of Sirt1 in vascular tissue, which includes ECs, monocytes/macrophages and VSMCs, may be a new therapeutic strategy against atherosclerosis and the increasing resistance to the metabolic disorder-related causal factors of CVD.
Abstract: Cardiovascular disease (CVD) due to atherosclerosis is the main cause of death in both the elderly and patients with metabolic diseases, including diabetes. Aging processes contribute to the pathogenesis of atherosclerosis. Calorie restriction (CR) is recognized as a dietary intervention for promoting longevity and delaying age-related diseases, including atherosclerosis. Sirt1, an NAD+-dependent deacetylase, is considered an anti-aging molecule and is induced during CR. Sirt1 deacetylates target proteins and is linked to cellular metabolism, the redox state and survival pathways. Sirt1 expression/activation is decreased in vascular tissue undergoing senescence. Sirt1 deficiency in endothelial cells (ECs), vascular smooth muscle cells (VSMCs) and monocytes/macrophages contributes to increased oxidative stress, inflammation, foam cell formation, senescences impaired nitric oxide production and autophagy, thereby promoting vascular aging and atherosclerosis. Endothelial dysfunction, activation of monocytes/macrophages, and the functional and phenotypical plasticity of VSMCs are critically implicated in the pathogenesis of atherosclerosis through multiple mechanisms. Therefore, the activation of Sirt1 in vascular tissue, which includes ECs, monocytes/macrophages and VSMCs, may be a new therapeutic strategy against atherosclerosis and the increasing resistance to the metabolic disorder-related causal factors of CVD. In this review, we discuss the protective role of Sirt1 in the pathophysiology of vascular aging and atherosclerosis.

184 citations


Authors

Showing all 3113 results

NameH-indexPapersCitations
Michael Marmot1931147170338
Tadamitsu Kishimoto1811067130860
Masayuki Yamamoto1711576123028
Zena Werb168473122629
Toshio Hirano12040155721
John T. Isaacs8835628217
Hiroshi Sasaki7664424222
Takuji Tanaka7549020946
Hiroshi Shimizu71136826668
Daisuke Koya6729418746
Masashi Tanaka6539617110
Masashi Akiyama6568516404
Masayoshi Takeuchi6427913651
Takashi Yoshida6332813680
Tsutomu Hatano6129913668
Network Information
Related Institutions (5)
Juntendo University
23.7K papers, 644.1K citations

95% related

Yokohama City University
19.8K papers, 520.3K citations

94% related

Tokyo Medical and Dental University
35.6K papers, 1M citations

93% related

Niigata University
35.1K papers, 819.7K citations

91% related

Nagasaki University
32.4K papers, 660.4K citations

90% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
20235
202217
2021371
2020327
2019268
2018273